Abstract
This study shows that different approaches may be required to reduce unsanctioned use of different pharmaceuticals due to differences in how drugs are sourced. The data also highlight that plans to monitor only Schedule 8 benzodiazepines and prescription opioids may have limited effects on prescription opioid users who use non-prescribed sources and may represent a lost opportunity for reducing unsanctioned benzodiazepine use.

This publication has 20 references indexed in Scilit: